Transitory neonatal hypoparathyroidism
ICD-10 P71.4 is a billable code used to indicate a diagnosis of transitory neonatal hypoparathyroidism.
Transitory neonatal hypoparathyroidism is a temporary condition characterized by a deficiency of parathyroid hormone (PTH) in newborns, leading to disturbances in calcium and magnesium metabolism. This condition often presents with hypocalcemia, which is a lower than normal level of calcium in the blood. In neonates, hypoparathyroidism can result from various factors, including maternal hypoparathyroidism, maternal vitamin D deficiency, or genetic predispositions. Clinically, affected infants may exhibit symptoms such as muscle twitching, irritability, seizures, or even cardiac arrhythmias due to low calcium levels. Diagnosis typically involves measuring serum calcium and PTH levels, and treatment may include calcium supplementation and monitoring. The condition is termed 'transitory' as it usually resolves within a few weeks to months as the infant's parathyroid glands mature and begin to function normally. Understanding this condition is crucial for neonatologists and pediatricians to ensure timely diagnosis and management, preventing potential complications associated with prolonged hypocalcemia.
Detailed records of clinical symptoms, laboratory results, and treatment plans are essential for accurate coding.
Neonates presenting with seizures or irritability due to hypocalcemia in the NICU.
Consideration of maternal health history, including any metabolic disorders, is crucial for accurate diagnosis and coding.
Documentation should include growth and development assessments, as well as follow-up on calcium levels.
Pediatric patients with a history of neonatal hypoparathyroidism presenting for routine check-ups.
Monitoring for potential long-term effects of transient hypoparathyroidism on growth and development.
Used to monitor calcium levels in neonates suspected of hypoparathyroidism.
Document the clinical rationale for testing and results interpretation.
Neonatologists should ensure that all relevant clinical data is included in the documentation.
Common symptoms include irritability, muscle twitching, seizures, and in severe cases, cardiac arrhythmias due to hypocalcemia.
